Semaphorin 7A coordinates Neutrophil response during pulmonary inflammation and sepsis.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
15 Mar 2024
Historique:
accepted: 06 02 2024
received: 25 09 2023
revised: 05 02 2024
medline: 15 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: aheadofprint

Résumé

Pulmonary defense mechanisms are critical for host integrity during pneumonia and sepsis. This defense is fundamentally dependent on the activation of neutrophils during the innate immune response. Recent work has shown that Semaphorin 7A (Sema7A) holds significant impact on platelet function, yet its role on neutrophil function within the lung is not well understood. To identify the role of Sema7A during pulmonary inflammation and sepsis. In ARDS patients we were able to show a correlation between Sema7A and oxygenation levels. During subsequent workup we found that Sema7A binds to the neutrophil PlexinC1 receptor, increasing integrins and L-selectin on neutrophils. Sema7A prompted neutrophil chemotaxis in-vitro and the formation of platelet-neutrophil complexes in-vivo. We also observed altered adhesion and transmigration of neutrophils in Sema7A-/- animals in the lung during pulmonary inflammation. This effect resulted in increased number of neutrophils in the interstitial space of Sema7A-/- animals but reduced numbers of neutrophils in the alveolar space during pulmonary sepsis. This finding was associated with significantly worse outcome of Sema7A-/- animals in a model of pulmonary sepsis. Sema7A has an immunomodulatory effect in the lung affecting pulmonary sepsis and ARDS. This effect influences the response of neutrophils to external aggression and might influence patient outcome.

Identifiants

pubmed: 38489236
pii: 515322
doi: 10.1182/bloodadvances.2023011778
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society of Hematology.

Auteurs

Tiago Folgosa Granja (TF)

University TÃ1/4bingen, TÃÂ1/4bingen, Germany.

David Köhler (D)

University of Tübingen, Tübingen, Germany.

Linyan Tang (L)

University Tübingen, Tübingen, Germany.

Philipp Burkard (P)

University Hospital Würzburg, Institute of Experimental Biomedicine, Würzburg, Germany, Würzburg, Germany.

Claudia Eggstein (C)

University Tübingen, Tübingen, Germany.

Katherina Hemmen (K)

University Würzburg, Wuerzburg, Germany.

Katrin G Heinze (KG)

University of Würzburg, WÃ1/4rzburg, Germany.

Ka-Lin Heck-Swain (KL)

University Tübingen, TÃ1/4bingen, Germany.

Michael Koeppen (M)

University Tübingen, TÃ1/4bingen, Germany.

Sven Günther (S)

University Tübingen, Tübingen, Germany.

Maximilian Klaus Blaha (MK)

University Tübingen, Tübingen, Germany.

Harry Magunia (H)

University Hospital Tübingen, Tübingen, Germany.

Maximilian Bamberg (M)

University TÃ1/4bingen, TÃÂ1/4bingen, Germany.

Franziska Magdalena Konrad (FM)

University of Tübingen, Tübingen, Germany.

Kristian-Christos Ngamsri (KC)

University of Tübingen.

Anika Fuhr (A)

University Tübingen, Tübingen, Germany.

Marius Keller (M)

University TÃ1/4bingen, TÃÂ1/4bingen, Germany.

Alice Bernard (A)

University of Tübingen, Tübingen, Germany.

Helene Haeberle (H)

University Hospital of Tuebingen, Tuebingen, Germany.

Tamam Bakchoul (T)

Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tübingen, Germany.

Alexander Zarbock (A)

University of Muenster, Muenster, Germany.

Bernhard Nieswandt (B)

Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, Würzburg, Germany.

Peter Rosenberger (P)

University Tübingen, Tübingen, Germany.

Classifications MeSH